Synopsys, Inc. $SNPS Shares Sold by Northwest & Ethical Investments L.P.

Northwest & Ethical Investments L.P. decreased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 1.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,526 shares of the semiconductor company’s stock after selling 660 shares during the period. Synopsys accounts for 0.7% of Northwest & Ethical Investments L.P.’s investment portfolio, making the stock its 28th biggest position. Northwest & Ethical Investments L.P.’s holdings in Synopsys were worth $29,985,000 as of its most recent filing with the SEC.

Other large investors have also made changes to their positions in the company. Nuveen LLC purchased a new position in Synopsys in the 1st quarter valued at about $341,480,000. Generation Investment Management LLP purchased a new stake in shares of Synopsys during the 1st quarter worth about $240,491,000. Vanguard Group Inc. lifted its position in Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after buying an additional 346,994 shares in the last quarter. Alliancebernstein L.P. raised its holdings in shares of Synopsys by 22.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after buying an additional 313,218 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Synopsys by 20.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after acquiring an additional 305,489 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Trading Down 0.7%

Shares of SNPS stock opened at $401.61 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The firm’s fifty day simple moving average is $443.58 and its 200 day simple moving average is $509.46. The firm has a market capitalization of $74.60 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last issued its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.77 billion. Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company’s revenue was up 14.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling at Synopsys

In other Synopsys news, Director Robert G. Painter bought 350 shares of the stock in a transaction that occurred on Thursday, September 11th. The shares were acquired at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the purchase, the director directly owned 2,291 shares in the company, valued at $974,683.04. The trade was a 18.03% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the sale, the chief financial officer directly owned 15,317 shares in the company, valued at approximately $9,339,847.09. This represents a 19.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 30,894 shares of company stock valued at $16,760,783 in the last 90 days. Insiders own 0.62% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on SNPS. Citigroup began coverage on shares of Synopsys in a research report on Monday. They issued a “buy” rating and a $580.00 price target on the stock. Wall Street Zen cut Synopsys from a “hold” rating to a “sell” rating in a report on Saturday, September 13th. Rosenblatt Securities reiterated a “neutral” rating and issued a $605.00 price target (down previously from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Baird R W downgraded Synopsys from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 10th. Finally, KeyCorp decreased their target price on shares of Synopsys from $660.00 to $590.00 and set an “overweight” rating for the company in a report on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $556.33.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.